Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma

British Journal of Surgery

Volumn 98, Issue 9, 2011, Pages 1210-1224

  Tiong, L ^a   Maddern, G J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

CATHETER ABLATION; CHEMOEMBOLIZATION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HUMAN; LAPAROSCOPY; LIVER CELL CARCINOMA; LIVER TUMOR; LOW LEVEL LASER THERAPY; META ANALYSIS; METHODOLOGY; MICROWAVE RADIATION; MORTALITY; REVIEW; SCLEROTHERAPY; TREATMENT OUTCOME; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE-FREE SURVIVAL; HUMANS; INTERFERONS; LAPAROSCOPY; LASER THERAPY; LIVER NEOPLASMS; MICROWAVES; NEOPLASM RECURRENCE, LOCAL; SCLEROTHERAPY; TREATMENT OUTCOME;

EID: 79960748644     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7669     Document Type: Review

References (98)

1. Lau WY, Lai EC,. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009; 249: 20-25.
2. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al.,; EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430. (Pubitemid 32844200)
3. El-Serag HB,. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35 (Suppl 2): S72-S78. (Pubitemid 35278644)
4. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, et al., Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000; 190: 580-587. (Pubitemid 30230706)
5. Llovet JM, Fuster J, Bruix J,. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440.
6. Margarit C, Escartin A, Castells L, Vargas V, Allende E, Bilbao I,. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005; 11: 1242-1251. (Pubitemid 41511939)
7. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, et al., Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9: 513-520. (Pubitemid 36621722)
8. Ikai I, Kudo M, Arii S, Omata M, Kojiro M, Sakamoto M, et al., Report of the 18th follow-up survey of primary liver cancer in Japan. Hepatol Res 2010; 40: 1043-1059.
9. Bruix J, Sherman M,; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236. (Pubitemid 43112690)
10. Ryder SD,. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52 (Suppl 3): iii1-iii8. (Pubitemid 36520856)
11. Scheele J, Stang R, Altendorf-Hofmann A, Paul M,. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
12. Pereira PL,. Actual role of radiofrequency ablation of liver metastases. Eur Radiol 2007; 17: 2062-2070. (Pubitemid 47097464)
13. McCarter MD, Fong Y,. Metastatic liver tumors. Semin Surg Oncol 2000; 19: 177-188.
14. Lehnert T, Golling M,. [Indications and outcome of liver metastases resection.] Radiologe 2001; 41: 40-48. (Pubitemid 32151040)
15. Abou-Alfa GK, Johnson P, Knox JJ, Capanu M, Davidenko I, Lacava J, et al., Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. JAMA 2010; 304: 2154-2160.
16. Buscarini E, Savoia A, Brambilla G, Menozzi F, Reduzzi L, Strobel D, et al., Radiofrequency thermal ablation of liver tumors. Eur Radiol 2005; 15: 884-894. (Pubitemid 41166720)
17. Scudamore CH, Lee SI, Patterson EJ, Buczkowski AK, July LV, Chung SW, et al., Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999; 177: 411-417. (Pubitemid 29252813)
18. Shigeki A, Michio S, Michiie S, Mitsuo S, Takashi K, Shuichiro S, et al., Evidence-based clinical practice guideline for hepatocellular carcinoma. Hepatol Res 2010; 40: 667-685.
19. Kudo M, Okanoue T,; Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72 (Suppl 1): 2-15. (Pubitemid 350256660)
20. Solazzo SA, Ahmed M, Liu Z, Hines-Peralta AU, Goldberg SN,. High-power generator for radiofrequency ablation: larger electrodes and pulsing algorithms in bovine ex vivo and porcine in vivo settings. Radiology 2007; 242: 743-750.
21. Schmidt D, Trübenbach J, Brieger J, Koenig C, Putzhammer H, Duda SH, et al., Automated saline-enhanced radiofrequency thermal ablation: initial results in ex vivo bovine livers. AJR Am J Roentgenol 2003; 180: 163-165. (Pubitemid 36008704)
22. Lee JM, Han JK, Kim SH, Shin KS, Lee JY, Park HS, et al., Comparison of wet radiofrequency ablation with dry radiofrequency ablation and radiofrequency ablation using hypertonic saline preinjection: ex vivo bovine liver. Korean J Radiol 2004; 5: 258-265.
23. Lee JM, Han JK, Kim SH, Choi SH, An SK, Han CJ, et al., Bipolar radiofrequency ablation using wet-cooled electrodes: an in vitro experimental study in bovine liver. AJR Am J Roentgenol 2005; 184: 391-397. (Pubitemid 46657238)
24. Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D'Onofrio M, et al., Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008; 12: 192-198.
25. Khan MR, Poon RT, Ng KK, Chan AC, Yuen J, Tung H, et al., Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma. Arch Surg 2007; 142: 1136-1143. (Pubitemid 350294266)
26. Iannitti DA, Dupuy DE, Mayo-Smith WW, Murphy B,. Hepatic radiofrequency ablation. Arch Surg 2002; 137: 422-426.
27. Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, Zheng Y, et al., Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 2007; 244: 599-607. (Pubitemid 47080894)
28. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al., Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214: 761-768. (Pubitemid 30115377)
29. Higgins JP, Green S,. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons: Chichester, 2008.
30. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. (Pubitemid 26120810)
31. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188. (Pubitemid 17189972)
32. Higgins J, Thompson S,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558. (Pubitemid 34746062)
33. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al., Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240. (Pubitemid 36736097)
34. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC,. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004; 127: 1714-1723.
35. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al., A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130. (Pubitemid 41002049)
36. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC,. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-1156.
37. Shibata T, Maetani Y, Isoda H, Hiraoka M,. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 2006; 238: 346-353. (Pubitemid 43010613)
38. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al., A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328. (Pubitemid 43327762)
39. Ferrari FS, Megliola A, Scorzelli A, Stella A, Vigni F, Drudi FM, et al., Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results. Radiol Med 2007; 112: 377-393. (Pubitemid 46663984)
40. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, et al., Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 2008; 299: 1669-1677. (Pubitemid 351519864)
41. Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, et al., Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 2008; 43: 727-735. (Pubitemid 351868714)
42. Yang P, Liang M, Zhang Y, Shen B,. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Advances in Therapy 2008; 25: 787-794.
43. Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K,. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010; 116: 5452-5460.
44. Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, et al., Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240: 102-107. (Pubitemid 38808241)
45. Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, et al., [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma.] Korean J Hepatol 2005; 11: 59-71.
46. Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, et al., Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005; 39: 247-252.
47. Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, et al., Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 2005; 40: 1054-1060. (Pubitemid 43055290)
48. Maluccio M, Covey AM, Gandhi R, Gonen M, Getrajdman GI, Brody LA, et al., Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol 2005; 16: 955-961. (Pubitemid 40993518)
49. Ogihara M, Wong LL, Machi J,. Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes. HPB (Oxford) 2005; 7: 214-221. (Pubitemid 41535854)
50. Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, et al., Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Clin Radiol 2005; 60: 1018-1025. (Pubitemid 41194673)
51. Chok KS, Ng KK, Poon RTP, Chi ML, Yuen J, Wai KT, et al., Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization. Arch Surg 2006; 141: 1231-1236. (Pubitemid 44956641)
52. Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, et al., Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Digestion 2007; 75: 104-112. (Pubitemid 47343961)
53. Kudo M, Sakaguchi Y, Chung H, Hatanaka K, Hagiwara S, Ishikawa E, et al., Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Oncology 2007; 72 (Suppl 1): 132-138. (Pubitemid 350256677)
54. Lin SM, Lin CC, Chen WT, Chen YC, Hsu CW,. Radiofrequency ablation for hepatocellular carcinoma: a prospective comparison of four radiofrequency devices. J Vasc Interv Radiol 2007; 18: 1118-1125.
55. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V,. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 2007; 9: 429-434. (Pubitemid 350215037)
56. Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, et al., Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Dig Dis 2007; 25: 303-309. (Pubitemid 350014957)
57. Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, et al., Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 2008; 55: 2171-2174.
58. Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, et al., Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 2008; 207: 20-29.
59. Seror O, N'Kontchou G, Tin-Tin-Htar M, Barrucand C, Ganne N, Coderc E, et al., Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis. J Vasc Interv Radiol 2008; 19: 718-724.
60. Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, et al., Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. J Gastroenterol Hepatol 2008; 23: 482-490. (Pubitemid 351342072)
61. Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, et al., Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008; 247: 260-266.
62. Kobayashi M, Ikeda K, Kawamura Y, Yatsuji H, Hosaka T, Sezaki H, et al., High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Cancer 2009; 115: 571-580.
63. Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, et al., Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. J Gastroenterol Hepatol 2009; 24: 223-237.
64. Santambrogio R, Opocher E, Zuin M, Selmi C, Bertolini E, Costa M, et al., Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class A liver cirrhosis. Ann Surg Oncol 2009; 16: 3289-3298.
65. Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, et al., Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009; 16: 359-366.
66. Yang W, Chen MH, Wang MQ, Cui M, Gao W, Wu W, et al., Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res 2009; 39: 231-240.
67. Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, et al., Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients. J Gastroenterol Hepatol 2010; 25: 403-407.
68. Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, et al., A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Eur J Surg Oncol 2010; 36: 257-263.
69. Murakami T, Ishimaru H, Sakamoto I, Uetani M, Matsuoka Y, Daikoku M, et al., Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol 2007; 30: 696-704. (Pubitemid 350092235)
70. Montorsi M, Santambrogio R, Bianchi P, Donadon M, Moroni E, Spinelli A, et al., Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 2005; 9: 62-67.
71. Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N,. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 2008; 12: 1521-1526.
72. Liang HH, Chen MS, Peng ZW, Zhang YJ, Zhang YQ, Li JQ, et al., Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol 2008; 15: 3484-3493.
73. Peng ZW, Zhang YJ, Chen MS, Lin XJ, Liang HH, Shi M,. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results. Eur J Surg Oncol 2010; 36: 1054-1060.
74. Kang TW, Rhim H, Kim EY, Kim YS, Choi D, Lee WJ, et al., Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy. Korean J Radiol 2009; 10: 34-42.
75. Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST,. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 2008; 12: 183-191.
76. Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY,. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 2010; 195: 758-765.
77. Kim SH, Lim HK, Choi D, Lee WJ, Kim SH, Kim MJ, et al., Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol 2006; 186 (Suppl): S327-S333. (Pubitemid 46114739)
78. Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, et al., Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-termresults in 117 patients. Radiology 2001; 221: 159-166. (Pubitemid 32880383)
79. Rhim H, Lim HK, Kim YS, Choi D, Lee WJ,. Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures. J Gastroenterol Hepatol 2008; 23: 1492-1500.
80. Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, et al., Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol 2005; 11: 6395-6401. (Pubitemid 43014011)
81. Gillams AR, Lees WR,. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-1213.
82. Li W, Ma K, Cheng M, Chui K, Chan P, Chu W, et al., Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ J Surg 2010; 80: 714-721.
83. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA,. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003; 10: 1059-1069. (Pubitemid 40486830)
84. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al., Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825.
85. Gleisner AL, Choti MA, Assumpcao L, Nathan H, Schulick RD, Pawlik TM,. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg 2008; 143: 1204-1212.
86. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, et al., A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003; 9: 684-692. (Pubitemid 36874454)
87. Freeman RB, Edwards EB, Harper AM,. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 2006; 6: 1416-1421. (Pubitemid 44030324)
88. Fisher RA, Maluf D, Cotterell AH, Stravitz T, Wolfe L, Luketic V, et al., Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant 2004; 18: 502-512. (Pubitemid 39264345)
89. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al., Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240: 900-909. (Pubitemid 39425785)
90. Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, et al., Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol 2007; 14: 2319-2329. (Pubitemid 47174899)
91. Minagawa M, Makuuchi M, Takayama T, Kokudo N,. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238: 703-710. (Pubitemid 38182262)
92. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, et al., Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234: 63-70. (Pubitemid 32619336)
93. Fong Y, Sun RL, Jarnagin W, Blumgart LH,. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790-799.
94. Makuuchi M, Takayama T, Kubota K, Kimura W, Midorikawa Y, Miyagawa S, et al., Hepatic resection for hepatocellular carcinoma-Japanese experience. Hepatogastroenterology 1998; 45 (Suppl 3): 1267-1274. (Pubitemid 28372112)
95. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229: 216-222. (Pubitemid 30191795)
96. Matsuda M, Fujii H, Kono H, Matsumoto Y,. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg 2001; 8: 353-359. (Pubitemid 33690560)
97. Kakazu T, Makuuchi M, Kawasaki S, Miyagawa S, Hashikura Y, Kosuge T, et al., Repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 1993; 40: 337-441.
98. Arii S, Monden K, Niwano M, Furutani M, Mori A, Mizumoto M, et al., Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg 1998; 5: 86-92. (Pubitemid 128662562)